Analyst Reco. Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Market Closed - Nasdaq Other stock markets 21:00:00 08/12/2025 GMT			5-day change	1st Jan Change
19.36 ^USD	-0.97%		+1.47%	+72.09%

11-13	Alignment Healthcare Insider Sold Shares Worth $2,936,772, According to a Recent SEC Filing	MT
10-31	UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating	MT

Analyst Reco.

UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating	10-31	MT
Alignment Healthcare's Strong Medicare Advantage Model Supports Better Results, Higher Savings, KeyBanc Says	08-25	MT
KeyBanc Upgrades Alignment Healthcare to Overweight From Sector Weight, Price Target is $21	08-25	MT
Alignment Healthcare Q2 revenue beats estimates; co raises annual outlook	07-30	RE
UBS Adjusts Alignment Healthcare Price Target to $17 From $16, Maintains Neutral Rating	05-02	MT
UBS Adjusts Price Target on Alignment Healthcare to $16 From $12, Keeps Neutral Rating	02-28	MT
Stephens Upgrades Alignment Healthcare to Overweight From Equalweight, Price Target is $17	12-03	MT
UBS Adjusts Price Target on Alignment Healthcare to $12 From $9, Maintains Neutral Rating	30/10/24	MT
KeyBanc Initiates Alignment Healthcare at Sector Weight	11/10/24	MT
UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating	02/08/24	MT
Alignment Healthcare Insider Sold Shares Worth $1,050,236, According to a Recent SEC Filing	22/07/24	MT
BofA Securities Upgrades Alignment Healthcare to Buy From Neutral, Raises Price Target to $11 From $7.75	30/05/24	MT
Baird Initiates Alignment Healthcare With Outperform Rating, $10 Price Target	30/05/24	MT
Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral	08/05/24	MT
UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating	03/05/24	MT
Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating	23/04/24	MT
Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12	06/03/24	MT
UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating	28/02/24	MT
Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target	24/01/24	MT
Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating	09/01/24	MT
UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating	21/12/23	MT
BofA Securities Downgrades Alignment Healthcare to Neutral From Buy	02/11/23	MT
Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9	16/10/23	MT
Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target	12/10/23	MT
Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating	30/08/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Analyst Reco.

Filters